In light of our prior discoveries indicating that SERPING1 overexpression could serve as a novel approach to impede tumor growth and extend survival, the evaluation of potential side effects and alternative indications of SERPING1 overexpression became paramount before contemplating clinical implementation. Here, SERPING1 is linked to neoplasm.